5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Abbott India Ltd.

•
abbott.co.inBSE: 500488NSE: ABBOTINDIA
Market Cap₹ 54,369 Cr.
Current Price
High / Low₹ 31,400 / 25,135
Stock P/E33.7
Book Value₹ 2,436
Price to Book11.60
Dividend Yield2.56 %
ROCE46.7 %
ROE34.7 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2022 • Injectables: 39.3% • Tablets: 38.6% • Liquids: 15.7%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 47.3%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 35.3%
  • Company has a consistent dividend-paying track record
  • Working capital cycle has improved - days down from 184 to 118
  • Stock looks reasonably valued - P/E of 33.7 is below its historical median

CONS

  • Stock is trading at 11.6x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY PHARMANIFTY MNCNIFTYLARGEMIDCAP250NIFTYMIDCAP150NIFTY MIDCAP 150
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.ABBOTINDIA25586.1033.6754368.682.56428.5217.131813.684.3346.7228.81
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
1,4791,4941,4371,4391,5581,6331,6141,6051,7381,7571,7241,7101,814
1,1241,1131,0491,1091,1671,1941,1781,1761,2931,2551,2611,2291,317
Operating Profit355381388330391439436429446502463481497
OPM %24.00%25.49%26.98%22.91%25.10%26.89%27.01%26.71%25.63%28.58%26.88%28.13%27.39%
56565681676072767370707675
Interest3333322468566
Depreciation17181818181818181919191920
Profit before Tax390415422390437479488483493546509531572
Tax %25.67%24.67%26.34%26.33%24.98%25.20%26.01%23.96%25.81%23.93%26.13%25.66%25.11%
Net Profit290313311287328359361367366415376395429
136.58147.27146.34135.09154.36168.76169.78172.72172.17195.42176.92185.85201.66

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
2,9033,2993,6794,0934,3104,9135,3495,8496,4096,9297,004
2,5082,7753,0753,3373,3913,8324,1434,3964,7175,0395,061
Operating Profit3955236047569191,0821,2051,4531,6921,8901,943
OPM %13.60%15.87%16.42%18.47%21.32%22.01%22.54%24.84%26.40%27.28%27.74%
601181141158383154248278290291
Interest242918191612112525
Depreciation1616176058667071727676
Profit before Tax4366216998039261,0801,2741,6181,8872,0792,158
Tax %36.62%35.44%35.56%26.13%25.41%26.03%25.47%25.75%25.04%25.36%25.19%
Net Profit2774014505936917999491,2011,4141,5521,615
EPS130.19188.81211.93279.04325.04375.86446.78565.28665.62730.36—
Dividend Payout %30.72%29.13%30.67%89.60%84.61%73.17%72.74%72.53%71.36%89.82%—

COMPOUNDED SALES GROWTH

10 Years:
10%
5 Years:
10%
3 Years:
9%

COMPOUNDED PROFIT GROWTH

10 Years:
20%
5 Years:
18%
3 Years:
18%

STOCK PRICE CAGR

10 Years:
19%
5 Years:
4%
3 Years:
4%
1 Year:
-18%

RETURN ON EQUITY

10 Years:
30%
5 Years:
34%
3 Years:
35%
Last Year:
35%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Jul 24

₹ 13.10

Rs.131.0000 per share(1310%)Special Dividend

2026

Jul 24

₹ 52.50

2025

Jul 25

₹ 47.50

Rs.475.0000 per share(4750%)Final Dividend

2024

Jul 19

₹ 41

Rs.410.0000 per share(4100%)Final Dividend

2023

Jul 21

₹ 14.50

08/09/2023 Equity Rs.145.0000 per share(1450%)Special Dividend

2023

Jul 21

₹ 18

08/09/2023 Equity Rs.145.0000 per share(1450%)Special Dividend

2022

Aug 2

₹ 13

Rs.130.0000 per share(1300%)Special Dividend

2022

Aug 2

₹ 14.50

2021

Jul 19

₹ 15.50

Rs.155.0000 per share(1550%)Special Dividend

2021

Jul 19

₹ 12

Rs.155.0000 per share(1550%)Special Dividend

2020

Aug 28

₹ 10.70

Rs.143.0000 per share(1430%)Special Dividend

2018

Jul 10

₹ 0.50

Rs.5.0000 per share(50%)Special Dividend

2018

Jul 10

₹ 5

Rs.50.0000 per share(500%)Final Dividend

2017

Jul 10

₹ 4

Rs.40.0000 per share(400%)Final Dividend

2016

Jul 8

₹ 3.50

Rs.35.0000 per share(350%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital21212121212121212121
1,3521,6511,9602,3752,5372,7543,1253,6374,1834,726
0001391181096737158134
Trade Payables4754816646587638898921,0031,0581,107
205249283340384433433479482488
Total Liabilities2,0532,4022,9283,5323,8234,2074,5395,1785,9026,476
11081105270251271237225336331
Capital Work in Progress521211410186
501585607527718688649620882947
0000000319380362
Cash & Bank1,0911,0311,6842,1972,4092,7491,9372,1341,6262,255
3477015315364454981,7121,8692,6602,575
Total Assets2,0532,4022,9283,5323,8234,2074,5395,1785,9026,476

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
4663587568559621,2371,2341,2131,0121,319
Cash from Investing-155-215-257-401-72-396-148-416182-371
Cash from Financing-90-102-143-217-582-637-639-745-925-1,066
62-16599873-8610752269-118

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
74.9974.9974.9974.9974.9974.9974.9974.9974.99
0.180.170.170.160.160.160.190.270.38
8.819.009.018.919.189.119.008.938.77
Government0.000.000.000.000.000.000.000.000.00
16.0215.8515.8415.9315.6615.7515.8315.8115.85

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for ABBOTINDIA

Loading news…

🤖

AI Stock Analyst

Abbott India Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login